This article reviews current patterns of ascertainment, clinical characteristics and quality of care for girls with Turner syndrome, based on a cohort of 100 girls (aged 7-17 years) prospectively evaluated at the National Institute of Child Health since 2001. Approximately 25% were diagnosed prenatally or at birth owing to webbed neck and other features typical of fetal lymphedema, few were diagnosed during early childhood, with the majority undiagnosed until age 9 years or older. Major clinical features included thyroid autoimmunity (51%), congenital cardiovascular anomalies (44%), liver abnormalities (36%), hypertension (34%), hearing loss (30%) and renal anomalies (18%). Of the group, 75% were being or had been treated with growth hormone. These girls were an average of 5 cm taller and significantly less obese than the untreated group. We discuss new guidelines for the initiation of puberty and urgent research needed to promote the health and longevity of girls suffering from Turner syndrome as they become adults. Keywords aorta; bicuspid aortic valve; lymphedema; phenotype; short stature; Turner syndrome; X chromosome Turner syndrome (TS) is a relatively common disorder of female development (affecting one out of 2000 births) caused by complete or partial monosomy for the X chromosome during embryonic development. The most consistent features are short stature and premature ovarian failure. Full-scale IQ is usually normal, with verbal scores typically greater than performance scores [1]. With timely diagnosis and intervention, girls with TS may gain improved height, benefit from attention to nonverbal learning difficulties early in school and have puberty at an age similar to their peers. Importantly, all these girls need comprehensive cardiovascular evaluation, since over a third have an underlying congenital cardiovascular defect that places them at an increased risk for life-threatening complications, such as pulmonary hypertension (e.g., partial anomalous pulmonary venous connection) or aortic dissection (i.e., bicuspid aortic valve or dilated ascending aorta). This article focuses on patterns of diagnosis and growth hormone (GH) (59%) are 45,X. The average age of our pediatric study subjects is 12.5 years, with a median of 13 years. The age of diagnosis demonstrates a distinct biphasic pattern ( Figure 1). Four girls were diagnosed prenatally, either incidentally during routine screening or because of an abnormal fetal ultrasound [2]. In total, 18 were diagnosed at birth because of neck webbing and associated signs of lymphedema and, in many cases, severe congenital heart disease. Surprisingly, very few girls were diagnosed during early childhood, despite the fact that growth failure is usually evident from shortly after birth [3], with 60% of girls not diagnosed until age 9 years or later.
PhenotypeCommon phenotypic features of the NIH pediatric TS study group are summarized in Table 1. Only 22% of the group had neck webbing, or pterygium colli. This feature is defined as the presence of (u...